X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Nath Bio-Genes (India) Ltd.
BSE CODE: 537291   |   NSE CODE: NATHBIOGEN   |   ISIN CODE : INE448G01010   |   18-May-2024 12:50 Hrs IST
BSE NSE
Rs. 195.85
1.55 ( 0.8% )
 
Prev Close ( Rs.)
194.30
Open ( Rs.)
195.95
 
High ( Rs.)
196.85
Low ( Rs.)
194.55
 
Volume
238
Week Avg.Volume
3194
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 195.90
1.3 ( 0.67% )
 
Prev Close ( Rs.)
194.60
Open ( Rs.)
193.05
 
High ( Rs.)
200.00
Low ( Rs.)
193.05
 
Volume
11838
Week Avg.Volume
43542
 
52 WK High-Low Range(Rs.)
159
244.6
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)18.50  -35.43  29.29  26.56  20.22  
   CEPS(Rs)20.09  -33.81  30.77  27.33  20.99  
   DPS(Rs)2.00  2.00  2.00  0.00  0.00  
   Book NAV/Share(Rs)301.70  285.19  322.71  293.42  267.09  
   Tax Rate(%)3.17  -6.23  1.92  -4.07  1.12  
Margin Ratios          
   Core EBITDA Margin(%)16.26  13.39  21.71  19.58  18.78  
   EBIT Margin(%)15.44  -18.95  21.33  19.71  19.14  
   Pre Tax Margin(%)12.05  -22.77  18.45  17.33  16.83  
   PAT Margin (%)11.67  -24.19  18.10  18.04  16.64  
   Cash Profit Margin (%)12.67  -23.08  19.01  18.56  17.27  
Performance Ratios          
   ROA(%)4.59  -8.81  7.33  7.33  6.31  
   ROE(%)6.31  -11.66  9.51  9.48  7.87  
   ROCE(%)7.09  -7.82  9.78  9.24  8.28  
   Asset Turnover(x)0.39  0.36  0.41  0.41  0.38  
   Sales/Fixed Asset(x)1.12  1.04  1.16  1.09  0.97  
   Working Capital/Sales(x)0.99  1.02  0.85  0.92  0.85  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.89  0.96  0.87  0.92  1.03  
   Receivable days110.76  127.81  128.40  140.20  150.21  
   Inventory Days259.37  292.83  255.51  234.52  220.34  
   Payable days744.29  1663.14  -1472.04  -528.37  -634.43  
Valuation Parameters          
   PER(x)7.66  0.00  10.24  5.12  22.84  
   PCE(x)7.05  -6.31  9.75  4.98  22.01  
   Price/Book(x)0.47  0.75  0.93  0.46  1.73  
   Yield(%)1.41  0.94  0.67  0.00  0.00  
   EV/Net Sales(x)1.12  1.78  2.09  1.10  3.96  
   EV/Core EBITDA(x)6.79  12.63  9.37  5.42  20.04  
   EV/EBIT(x)7.23  -9.37  9.78  5.56  20.69  
   EV/CE(x)0.42  0.67  0.81  0.42  1.41  
   M Cap / Sales0.89  1.46  1.85  0.92  3.80  
Growth Ratio          
   Net Sales Growth(%)8.24  -9.49  9.89  21.20  20.49  
   Core EBITDA Growth(%)26.63  -42.83  20.87  24.05  10.25  
   EBIT Growth(%)188.22  -180.38  18.95  24.82  9.26  
   PAT Growth(%)152.22  -220.98  10.26  31.35  30.64  
   EPS Growth(%)152.22  -220.98  10.26  31.35  30.64  
Financial Stability Ratios          
   Total Debt/Equity(x)0.18  0.17  0.16  0.13  0.11  
   Current Ratio(x)2.41  2.41  3.10  2.78  2.95  
   Quick Ratio(x)1.45  1.27  1.79  1.58  1.83  
   Interest Cover(x)4.56  -4.96  7.40  8.29  8.30  
   Total Debt/Mcap(x)0.39  0.23  0.18  0.27  0.07